Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy.
A case of acquired von Willebrand's syndrome (avWs) secondary to benign monoclonal gammopathy, is described, in which desmopressin (DDAVP) has proven effective repeatedly in preventing bleeding after tooth extraction. The laboratory pattern was similar to that of congenital type IA von Willebrand's disease. After DDAVP, prolonged bleeding time and factor VIII/von Willebrand factor activities were normalized. The disappearance rate of the elicited activities was similar to that observed in patients with congenital disease. This report adds to the scarce data concerning the haemostatic effectiveness of DDAVP in avWs and suggests that this agent might also be used in controlling or preventing bleeding in patients with the acquired disease, selected on the basis of their biological responsiveness to a test-infusion.
Castaman
G
G
Department of Haematology and Haemophilia, San Bortolo Hospital, Vicenza, Italy.
Rodeghiero
F
F
Di Bona
E
E
Ruggeri
M
M
D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D006472:Oral Hemorrhage / Q000209:etiology / Q000517:prevention & control; D010265:Paraproteinemias / Q000150:complications*; D014081:Tooth Extraction / Q000009:adverse effects; D014842:von Willebrand Diseases / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D014841:von Willebrand Factor / Q000097:blood
D014841:von Willebrand Factor; D003894:Deamino Arginine Vasopressin